Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.29%34.59B | 9.85%22.72B | 9.35%10.89B | 15.26%44.28B | 12.81%31.36B | 10.48%20.69B | 10.87%9.96B | 8.60%38.42B | 8.99%27.8B | 13.06%18.72B |
| Operating income | 10.29%34.59B | 9.85%22.72B | 9.35%10.89B | 15.26%44.28B | 12.81%31.36B | 10.48%20.69B | 10.87%9.96B | 8.60%38.42B | 8.99%27.8B | 13.06%18.72B |
| Cost of sales | -21.47%-26B | -21.52%-17.09B | -17.88%-8.2B | -14.23%-30.56B | -11.10%-21.4B | -9.05%-14.06B | -7.71%-6.96B | -1.59%-26.76B | -0.14%-19.27B | -1.23%-12.9B |
| Operating expenses | -21.47%-26B | -21.52%-17.09B | -17.88%-8.2B | -14.23%-30.56B | -11.10%-21.4B | -9.05%-14.06B | -7.71%-6.96B | -1.59%-26.76B | -0.14%-19.27B | -1.23%-12.9B |
| Gross profit | -13.74%8.59B | -14.93%5.63B | -10.42%2.69B | 17.62%13.72B | 16.68%9.96B | 13.64%6.62B | 18.97%3B | 29.02%11.66B | 36.18%8.53B | 52.47%5.83B |
| Selling expenses | 1.99%-1.99B | 8.63%-1.36B | 17.75%-737.51M | -10.92%-2.69B | -17.93%-2.03B | -15.37%-1.49B | -13.99%-896.64M | -16.75%-2.43B | -13.74%-1.72B | -20.10%-1.29B |
| Special items of operating profit | 72.18%689.6M | 74.22%607.94M | 181.33%453.67M | -2.71%749.78M | -9.68%400.51M | 19.26%348.96M | -24.52%161.26M | -0.51%770.65M | -15.77%443.45M | -17.49%292.6M |
| Operating profit | -12.47%7.29B | -10.97%4.88B | 6.12%2.41B | 17.68%11.78B | 14.76%8.32B | 13.52%5.48B | 16.21%2.27B | 29.36%10.01B | 37.45%7.25B | 55.69%4.83B |
| Financing income | -23.23%592.36M | -23.63%407.12M | -19.03%198.39M | 40.58%993.54M | 52.68%771.61M | 105.81%533.1M | 166.58%245.02M | 40.31%706.77M | 28.94%505.38M | 12.82%259.02M |
| Financing cost | 16.81%-221.41M | 16.41%-166.99M | 17.92%-68.88M | -16.71%-337.92M | -16.86%-266.14M | -38.80%-199.77M | -17.02%-83.92M | -51.97%-289.53M | -99.11%-227.73M | -73.96%-143.93M |
| Special items of earning before tax | 116.67%107.51M | 92.69%-39.65M | 107.61%32.72M | -387.21%-756.93M | -313.95%-644.85M | -295.60%-542.54M | -395.69%-429.81M | 11.31%263.55M | 123.07%301.41M | 199.91%277.37M |
| Earning before tax | -5.14%7.76B | -3.64%5.08B | 28.51%2.57B | 9.23%11.68B | 4.50%8.18B | 0.98%5.27B | -5.58%2B | 28.99%10.69B | 37.66%7.83B | 56.28%5.22B |
| Tax | 29.06%-1.27B | 10.09%-1.11B | 6.13%-531.57M | -46.77%-2.85B | -37.20%-1.79B | -19.48%-1.23B | -24.46%-566.31M | -18.69%-1.94B | -14.93%-1.3B | -48.62%-1.03B |
| After-tax profit from continuing operations | 1.54%6.5B | -1.67%3.97B | 42.21%2.04B | 0.92%8.83B | -2.02%6.4B | -3.57%4.04B | -13.81%1.43B | 31.52%8.75B | 43.31%6.53B | 58.29%4.19B |
| Special items of earning after tax | 6.63%45.58M | 46.72%29.89M | -80.41%3.15M | 1,217.95%57.41M | 190.19%42.75M | 416.16%20.37M | 319.85%16.06M | -25.46%4.36M | 154.86%14.73M | 129.25%3.95M |
| Earning after tax | 1.58%6.54B | -1.43%4B | 40.85%2.04B | 1.52%8.89B | -1.59%6.44B | -3.18%4.06B | -13.04%1.45B | 31.47%8.75B | 44.48%6.54B | 59.25%4.2B |
| Minority profit | 1,212.23%87.15M | 201.98%72.16M | 111.67%45.93M | 1,197.63%70.76M | 155.09%6.64M | 244.77%23.9M | 493.49%21.7M | 103.63%5.45M | 89.68%-12.05M | 78.63%-16.51M |
| Profit attributable to shareholders | 0.33%6.46B | -2.63%3.93B | 39.77%1.99B | 0.78%8.82B | -1.87%6.43B | -4.12%4.04B | -14.63%1.43B | 28.49%8.75B | 41.11%6.56B | 55.32%4.21B |
| Basic earnings per share | 1.13%8.08 | -1.80%4.92 | 41.24%2.5 | 1.11%10.95 | -1.48%7.99 | -3.84%5.01 | -14.49%1.77 | 28.78%10.83 | 41.29%8.11 | 55.52%5.21 |
| Diluted earnings per share | 1.28%7.9 | -1.84%4.81 | 39.43%2.44 | 0.94%10.7 | -1.76%7.8 | -3.92%4.9 | -13.79%1.75 | 26.79%10.6 | 38.57%7.94 | 52.24%5.1 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unaudited opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.